Hyperfine (HYPR) Cash from Financing Activities (2021 - 2026)

Hyperfine (HYPR) reported Cash from Financing Activities of $14.5 million for Q1 2026, up 159.51% on a YoY basis from $5.6 million in Q1 2025, and down 24.87% quarter-over-quarter from $19.3 million in Q4 2025.

Hyperfine (HYPR) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Hyperfine has reported Cash from Financing Activities for 6 years, with the latest figure at $14.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 159.51% year-over-year to $14.5 million; the trailing twelve-month figure through Mar 2026 stood at $36.4 million (up 456.16% YoY), and the FY2025 full-year result was $27.5 million, up 2598.92% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $14.5 million, down from $19.3 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $19.3 million in Q4 2025, with the low at $5000.0 in Q4 2022.
  • Historically, Cash from Financing Activities has averaged $3.1 million across 5 years, with a median of $58500.0 in 2023.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities slumped 100.0% — and 2025, when it jumped 35607.41%.
  • Hyperfine's Cash from Financing Activities stood at $5000.0 in 2022, then surged by 460.0% to $28000.0 in 2023, then surged by 92.86% to $54000.0 in 2024, then jumped by 35607.41% to $19.3 million in 2025, then dropped by 24.87% to $14.5 million in 2026.
  • The last three Cash from Financing Activities figures came in at $14.5 million (Q1 2026), $19.3 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Hyperfine 155.82 Mn 114.55 Mn 1.98 Mn 14.49 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.49 Mn
Mar 31, 2026 14.49 Mn
Dec 31, 2025 19.28 Mn
Dec 31, 2025 19.28 Mn
Sep 30, 2025 2.16 Mn
Sep 30, 2025 2.16 Mn
Jun 30, 2025 474,000.00
Jun 30, 2025 474,000.00
Mar 31, 2025 5.58 Mn
Mar 31, 2025 5.58 Mn
Dec 31, 2024 54,000.00
Dec 31, 2024 54,000.00
Sep 30, 2024 851,000.00
Sep 30, 2024 851,000.00
Jun 30, 2024 59,000.00
Jun 30, 2024 59,000.00
Mar 31, 2024 55,000.00
Mar 31, 2024 55,000.00
Dec 31, 2023 28,000.00
Dec 31, 2023 28,000.00